Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Octreotide acetate
Trade Name Sandostatin Lar Depot
Synonyms SMS 201-995
Drug Descriptions

Sandostatin Lar Depot (octreotide acetate) mimics the activity of somatostatin, which may control the growth of neuroendocrine tumors (PMID: 26605828). Sandostatin Lar Depot (octreotide acetate) is FDA approved for symptom control in patients with carcinoid tumors and VIPomas (FDA.gov).

CAS Registry Number 79517-01-4
NCIT ID C53447


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Cixutumumab + Everolimus + Octreotide acetate Cixutumumab Everolimus Octreotide acetate 0 0
Debio 4126 + Octreotide acetate Debio 4126 Octreotide acetate 0 1
Everolimus + Octreotide acetate Everolimus Octreotide acetate 0 1
lutetium Lu 177 dotatate + Octreotide acetate Octreotide acetate lutetium Lu 177 dotatate 0 1
Octreotide acetate Octreotide acetate 0 3

Additional content available in CKB BOOST